QIAGEN Digital Insights (QDI) is the bioinformatics business of QIAGEN, offering a comprehensive portfolio of software, databases, and services to translate biological data into actionable molecular insights, from basic research to patient care. The platform was established in 2014, based on the acquisitions of Ingenuity, CLC bio, and BIOBASE, and has since integrated other solutions like OmicSoft and N-of-One.
QDI is built upon a foundation of a highly structured, human-curated knowledge base, leveraging over 40 different data sources, thousands of journal citations, and over 40 billion scientific data points. This knowledge base is used to power key product lines:
- QIAGEN Ingenuity Pathway Analysis (IPA): A web-based application for modeling, analyzing, and understanding complex 'omics data (gene expression, RNA-seq, SNP, metabolomics, proteomics). It identifies upstream regulators, signaling/metabolic pathways, and predicts effects on downstream diseases and functions.
- QIAGEN Clinical Insight (QCI): Clinical decision support software for variant interpretation and reporting for hereditary diseases and oncology, used in over 4.5 million NGS test cases.
- QIAGEN CLC Genomics Workbench: A cross-platform desktop and server solution for Next-Generation Sequencing (NGS) data analysis, visualization, and complete data analysis workflows.
The software portfolio supports automated, validated workflows for consistent, audit-ready compliance, including GMP requirements, and is expanding its offerings with AI-driven solutions for enhanced interpretation.